Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

INSPIRIS China PMCF Study

NCT: NCT05404880 · ACTIVE_NOT_RECRUITING

NCT IDNCT05404880
StatusACTIVE_NOT_RECRUITING
Start Date2022-07-13
SponsorEdwards Lifesciences (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this post-market trial is to evaluate long term safety and performance of the Edwards Lifesciences INSPIRIS RESILIA aortic valve in Chinese patients in a real-world clinical setting.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑